Regarding dissolution of Vetoquinol Zenoaq Co., Ltd and establishment of Vetoquinol Japan Co., Ltd

Vetoquinol (Headquarters: Lure, France, CEO: Matthieu Frechin, hereafter Vetoquinol) and Nippon...

October 2021

Third quarter revenues: €132 million +14.3% at constant exchange rates

Third quarter sales of Essential products: €75 million +26.0% at constant exchange rates Vetoquinol...

October 2021

investor of environement

Vetoquinol UK achieves bronze accreditation with Investors in the Environment

Veterinary pharmaceuticals company, Vetoquinol UK, has achieved bronze accreditation with Investors...

October 2021

Vetoquinol welcomes the Positive Opinion from the European Committee for Medicinal Products for Veterinary Use (CVMP) recommending parasiticide Felpreva® for cats

We are pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP) has...

September 2021

Innovation - New light therapy supports skin recovery in pets

For faster skin recovery in dogs and cats, Vetoquinol has just introduced mid-May in the first...

June 2021

Q1 2021 Sales

Q1 2021 SALES: €128M (UP 28% AT CONSTANT EXCHANGE RATES, UP 24% AS REPORTED) Q1 2021 ESSENTIALS...

April 2021

2020 annual results

2020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from...

March 2021

Animal Health Award Winner 2020

Vetoquinol wins the animal pharm’s award for best european company 2020

February 8 th, 2021 (Lure, France) - Vetoquinol announced today it has been awarded “Best European...

February 2021

Vetoquinol acquires the rights for Profender® from Elanco animal health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian...

February 2021